https://www.prnewswire.com/news-releases/cti-issues-statement-regarding-tosedostat-clinical-trial-212867041.html
CTI Issues Statement Regarding Tosedostat Clinical Trial
/PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today issued the following statement regarding the notification of the U.S. Food and...
ctiissuesstatementregardingclinical